[EN] IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA [FR] INHIBITEURS D'IMIDAZOPYRIDAZINE KINASE UTILES POUR LE TRAITEMENT D'UNE MALADIE OU D'UN TROUBLE INDUIT PAR AAK1, TELS QUE LA MALADIE D'ALZHEIMER, UN TROUBLE BIPOLAIRE, LA DOULEUR, LA SCHIZOPHRÉNIE
[EN] IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA [FR] INHIBITEURS D'IMIDAZOPYRIDAZINE KINASE UTILES POUR LE TRAITEMENT D'UNE MALADIE OU D'UN TROUBLE INDUIT PAR AAK1, TELS QUE LA MALADIE D'ALZHEIMER, UN TROUBLE BIPOLAIRE, LA DOULEUR, LA SCHIZOPHRÉNIE
[EN] SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS<br/>[FR] IMIDAZOPYRIDAZINES SUBSTITUÉES UTILES EN TANT QU'INHIBITEURS DE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009100375A1
公开(公告)日:2009-08-13
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS
申请人:Vaccaro Wayne
公开号:US20080045536A1
公开(公告)日:2008-02-21
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof,
are useful as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR
3
, and R
1
, R
2
, R
3
, X and Y are as defined herein.
Substituted imidazopyridazines useful as kinase inhibitors
申请人:Fink Brian E.
公开号:US08389527B2
公开(公告)日:2013-03-05
The invention provides compounds of formula I
and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA
申请人:Bristol-Myers Squibb Company
公开号:US20160199372A1
公开(公告)日:2016-07-14
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS
申请人:Fink Brian E.
公开号:US20100323994A1
公开(公告)日:2010-12-23
The invention provides compounds of formula I
and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.